Benefits and Prerequisites Associated with the Adoption of Oral 3D-Printed Medicines for Pediatric Patients : A Focus Group Study among Healthcare Professionals

Show full item record



Permalink

http://hdl.handle.net/10138/314688

Citation

Rautamo , M M , Kvarnström , K , Siven , M , Airaksinen , M , Lahdenne , P O & Sandler , N 2020 , ' Benefits and Prerequisites Associated with the Adoption of Oral 3D-Printed Medicines for Pediatric Patients : A Focus Group Study among Healthcare Professionals ' , Pharmaceutics , vol. 12 , no. 3 , 229 . https://doi.org/10.3390/pharmaceutics12030229

Title: Benefits and Prerequisites Associated with the Adoption of Oral 3D-Printed Medicines for Pediatric Patients : A Focus Group Study among Healthcare Professionals
Author: Rautamo, Maria M; Kvarnström, Kirsi; Siven, Mia; Airaksinen, Marja; Lahdenne, Pekka Olavi; Sandler, Niklas
Contributor: University of Helsinki, Doctoral Programme in Drug Research
University of Helsinki, Doctoral Programme in Drug Research
University of Helsinki, Teachers' Academy
University of Helsinki, Helsinki One Health (HOH)
University of Helsinki, HUS Children and Adolescents
Date: 2020-03-05
Language: eng
Number of pages: 11
Belongs to series: Pharmaceutics
ISSN: 1999-4923
URI: http://hdl.handle.net/10138/314688
Abstract: The utilization of three-dimensional (3D) printing technologies as innovative manufacturing methods for drug products has recently gained growing interest. From a technological viewpoint, proof-of-concept on the performance of different printing methods already exist, followed by visions about future applications in hospital or community pharmacies. The main objective of this study was to investigate the perceptions of healthcare professionals in a tertiary university hospital about oral 3D-printed medicines for pediatric patients by means of focus group discussions. In general, the healthcare professionals considered many positive aspects and opportunities in 3D printing of pharmaceuticals. A precise dose as well as personalized doses and dosage forms were some of the advantages mentioned by the participants. Especially in cases of polypharmacy, incorporating several drug substances into one product to produce a polypill, personalized regarding both the combination of drug substances and the doses, would benefit drug treatments of several medical conditions and would improve adherence to medications. In addition to the positive aspects, concerns and prerequisites for the adoption of 3D printing technologies at hospital settings were also expressed. These perspectives are suggested by the authors to be focus points for future research on personalized 3D-printed drug products.
Subject: 317 Pharmacy
children
pediatrics
3D printing
3D-printed medicines
personalized medication
healthcare professionals
hospital pharmacy
focus group study
PRINTING TECHNOLOGIES
ORODISPERSIBLE FILMS
DOSAGE FORMS
EXCIPIENTS
ACCEPTABILITY
DELIVERY
SMART
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
pharmaceutics_12_00229.pdf 1.030Mb PDF View/Open
pharmaceutics_12_00229.pdf 1.033Mb PDF View/Open

This item appears in the following Collection(s)

Show full item record